05:12 PM EDT, 05/29/2024 (MT Newswires) -- Fusion Pharmaceuticals ( FUSN ) said late Wednesday it received shareholder approval for the company's proposed acquisition by AstraZeneca ( AZN ) .
The company said the deal is expected to close in Q2, subject to court approval and other conditions.